Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$14M Sell
125,800
-1,876
-1% -$224K 0.01% 775
2023
Q4
$16.6M Buy
127,676
+71,085
+126% +$9.8M 0.02% 714
2023
Q3
$9.23M Buy
56,591
+12,856
+29% +$2.26M 0.01% 934
2023
Q2
$8.02M Buy
43,735
+4,574
+12% +$658K 0.01% 1040
2023
Q1
$5.22M Sell
39,161
-3,637
-8% -$427K 0.01% 1283
2022
Q4
$3.4M Buy
42,798
+1,445
+3% +$102K ﹤0.01% 1558
2022
Q3
$2.5M Buy
41,353
+16,203
+64% +$1.05M ﹤0.01% 1696
2022
Q2
$1.38M Sell
25,150
-3,171
-11% -$184K ﹤0.01% 2165
2022
Q1
$2.14M Buy
28,321
+4,246
+18% +$290K ﹤0.01% 2032
2021
Q4
$1.79M Sell
24,075
-1,342
-5% -$79.5K ﹤0.01% 2873
2021
Q3
$1.2M Sell
25,417
-2,590
-9% -$113K ﹤0.01% 3195
2021
Q2
$1.13M Sell
28,007
-10,271
-27% -$426K ﹤0.01% 3293
2021
Q1
$1.57M Sell
38,278
-1,339
-3% -$49.9K ﹤0.01% 2994
2020
Q4
$1.15M Buy
39,617
+13,617
+52% +$352K ﹤0.01% 3242
2020
Q3
$572K Sell
26,000
-4,159
-14% -$106K ﹤0.01% 3309
2020
Q2
$840K Sell
30,159
-54,611
-64% -$1.33M ﹤0.01% 2998
2020
Q1
$1.55M Buy
84,770
+32,986
+64% +$766K ﹤0.01% 2302
2019
Q4
$1.25M Buy
51,784
+20,181
+64% +$425K ﹤0.01% 2972
2019
Q3
$540K Buy
31,603
+2,250
+8% +$36K ﹤0.01% 3397
2019
Q2
$441K Sell
29,353
-8,997
-23% -$161K ﹤0.01% 3481
2019
Q1
$771K Buy
38,350
+793
+2% +$16.1K ﹤0.01% 3086
2018
Q4
$668K Buy
37,557
+10,948
+41% +$195K ﹤0.01% 3094
2018
Q3
$523K Sell
26,609
-1,383
-5% -$28.5K ﹤0.01% 3268
2018
Q2
$554K Sell
27,992
-2,891
-9% -$63.6K ﹤0.01% 3369
2018
Q1
$761K Sell
30,883
-7,243
-19% -$190K ﹤0.01% 3142
2017
Q4
$1.09M Buy
38,126
+2,713
+8% +$85.4K ﹤0.01% 2921
2017
Q3
$969K Buy
35,413
+15,278
+76% +$338K ﹤0.01% 3124
2017
Q2
$423K Buy
+20,135
New +$425K ﹤0.01% 3262
2017
Q1
Sell
-14,458
Closed -$210K 3784
2016
Q4
$210K Buy
14,458
+874
+6% +$11.9K ﹤0.01% 3794
2016
Q3
$180K Buy
+13,584
New +$158K ﹤0.01% 3838
2016
Q2
Sell
-8,653
Closed -$97K 4187
2016
Q1
$97K Sell
8,653
-1,223
-12% -$12.5K ﹤0.01% 3831
2015
Q4
$103K Sell
9,876
-17,258
-64% -$183K ﹤0.01% 4068
2015
Q3
$290K Sell
27,134
-9,147
-25% -$111K ﹤0.01% 3735
2015
Q2
$430K Buy
36,281
+21,614
+147% +$250K ﹤0.01% 3816
2015
Q1
$140K Buy
14,667
+1,611
+12% +$16.6K ﹤0.01% 4168
2014
Q4
$134K Buy
13,056
+3,617
+38% +$31.4K ﹤0.01% 4379
2014
Q3
$76K Sell
9,439
-3,231
-26% -$24.3K ﹤0.01% 4328
2014
Q2
$101K Sell
12,670
-22,355
-64% -$167K ﹤0.01% 4533
2014
Q1
$301K Sell
35,025
-7,232
-17% -$66.5K ﹤0.01% 4098
2013
Q4
$413K Buy
42,257
+23,345
+123% +$212K ﹤0.01% 3878
2013
Q3
$160K Buy
18,912
+5,186
+38% +$42K ﹤0.01% 4026
2013
Q2
$100K Buy
+13,726
New +$79.7K ﹤0.01% 4015

Other funds holding ACLS

Credit Suisse's ACLS Position: Q1 2024 in Review

Credit Suisse reduced its Axcelis (ACLS) stake by 1.5% in Q1 2024, selling an estimated $224K and leaving 125,800 shares worth $14M. The position accounts for 0.01% of the portfolio, ranked #775.

Credit Suisse first reported a position in ACLS in Q2 2013 and has held it in 42 quarters since. The position peaked at $16.6M in Q4 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • Credit Suisse held 125,800 shares of Axcelis worth $14M as of Q1 2024.
  • Credit Suisse sold 1,876 Axcelis shares in Q1 2024, an estimated $224K.
  • Axcelis made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #775 holding.
  • Credit Suisse first reported a position in Axcelis in Q2 2013 and has held it in 42 quarters since.
  • Credit Suisse's Axcelis position peaked at $16.6M in Q4 2023.
  • 385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.